{
"@context": "https://schema.org",
"@type": "Article",
"headline": "FDA and DEA approve CBD-based epilepsy medication",
"url": "https://www.lexblog.com/2018/10/03/fda-and-dea-approve-cbd-based-epilepsy-medication/",
"identifier": {
"@type": "PropertyValue",
"name": "LexBlog Library record",
"value": "LEX-WK-NG8MXYHQ",
"url": "https://www.lexblog.com/lib/NG8MXYHQ/"
},
"datePublished": "2018-10-03T00:00:00-04:00",
"dateModified": "2018-10-16T15:54:31-04:00",
"author": {
"@type": "Person",
"name": "Marc J. Adesso"
},
"sourceOrganization": {
"@type": "Organization",
"name": "Waller"
},
"organizationScope": "at-publication",
"isPartOf": "Waller Law Blogs",
"about": "Health Care and Life Sciences",
"sourceUrl": "http://www.wallerlawblog.com/post/586/fda-and-dea-approve-cbd-based-epilepsy-medication",
"sourceStability": "may-move"
}